Perspective Therapeutics
CATX
32 hedge funds and large institutions have $1.83M invested in Perspective Therapeutics in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
7% more funds holding
Funds holding: 30 → 32 (+2)
5% more capital invested
Capital invested by funds: $1.74M → $1.83M (+$85K)
0.14% less ownership
Funds ownership: 0.87% → 0.73% (-0.14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPIG
Chicago Partners Investment Group
Chicago,
Illinois
|
+$13.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$8.76K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$6.35K |
| 4 |
CWM
Cornerstone Wealth Management
St. Peters,
Missouri
|
+$3.98K |
| 5 |
MC
Moors & Cabot
Boston,
Massachusetts
|
+$3.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$381K |
| 2 |
VF
Virtu Financial
New York
|
-$14.7K |
| 3 |
Invesco
Atlanta,
Georgia
|
-$5K |
| 4 |
Bank of New York Mellon
New York
|
-$800 |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$780 |
CATX Hedge Fund Activity: Q1 2019 in Review
32 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q1 2019, worth a combined $1.83M — up 4.9% from $1.74M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CATX positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Chicago Partners Investment Group, opening a new position worth an estimated $13.5K. The largest seller was Sabby Management, cutting an estimated $381K.
- 32 institutional investors held Perspective Therapeutics (CATX) as of Q1 2019, up from 30 in Q4 2018.
- Funds reported $1.83M of Perspective Therapeutics stock for Q1 2019, up 4.9% quarter-over-quarter.
- 3 funds opened new Perspective Therapeutics positions in Q1 2019 and 1 closed out, a net change of +2 holders.
- The largest Perspective Therapeutics buyer in Q1 2019 was Chicago Partners Investment Group, an estimated $13.5K added.
- The largest Perspective Therapeutics seller in Q1 2019 was Sabby Management, an estimated $381K sold.
Based on aggregated 13F filings for Q1 2019.